List of works - Michael J Keiser

A Simple Representation of Three-Dimensional Molecular Structure.

scientific article published on 21 July 2017

A mapping of drug space from the viewpoint of small molecule metabolism

scientific article

A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.

scientific article published on January 2010

Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction

scientific article published on 27 November 2020

Adversarial Controls for Scientific Machine Learning

scientific article published on 01 October 2018

Chemical informatics and target identification in a zebrafish phenotypic screen.

scientific article published on 18 December 2011

Comment on "Predicting reaction performance in C-N cross-coupling using machine learning"

scientific article published on 01 November 2018

Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors

scientific article

Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior

scientific article

In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding

scientific article (publication date: November 2013)

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

scientific article published on 15 May 2019

Learning Molecular Representations for Medicinal Chemistry

scientific article published on 04 May 2020

Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology

scientific article

Off-target networks derived from ligand set similarity

scientific article published in January 2009

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach

scientific article published on 22 February 2016

Predicted Biological Activity of Purchasable Chemical Space.

scientific article published in December 2017

Predicting new molecular targets for known drugs

scientific article

Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.

scientific article

Prediction and validation of enzyme and transporter off-targets for metformin.

scientific article published on 3 September 2015

Quantifying biogenic bias in screening libraries

scientific article

Quantifying the relationships among drug classes

scientific article published on 13 March 2008

Systems pharmacology augments drug safety surveillance

scientific article

The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders

article by A Jeremy Willsey et al published 26 July 2018 in Cell

The presynaptic component of the serotonergic system is required for clozapine's efficacy.

scientific article

Validation of machine learning models to detect amyloid pathologies across institutions

scientific article published on 28 April 2020

Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds.

scientific article

Zebrafish behavioural profiling identifies GABA and serotonin receptor ligands related to sedation and paradoxical excitation

scientific article published on 09 September 2019

List of works by Michael J Keiser

A Simple Representation of Three-Dimensional Molecular Structure.

A mapping of drug space from the viewpoint of small molecule metabolism

A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.

Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction

Adversarial Controls for Scientific Machine Learning

Chemical informatics and target identification in a zebrafish phenotypic screen.

Comment on "Predicting reaction performance in C-N cross-coupling using machine learning"

Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors

Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior

In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Learning Molecular Representations for Medicinal Chemistry

Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology

Off-target networks derived from ligand set similarity

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach

Predicted Biological Activity of Purchasable Chemical Space.

Predicting new molecular targets for known drugs

Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.

Prediction and validation of enzyme and transporter off-targets for metformin.

Quantifying biogenic bias in screening libraries

Quantifying the relationships among drug classes

Systems pharmacology augments drug safety surveillance

The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders

The presynaptic component of the serotonergic system is required for clozapine's efficacy.

Validation of machine learning models to detect amyloid pathologies across institutions

Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds.

Zebrafish behavioural profiling identifies GABA and serotonin receptor ligands related to sedation and paradoxical excitation